DASPHARMA - Dannex Ayrton Starwin Plc
Dannex Ayrton Starwin Plc is the largest pharmaceutical manufacturing company in Ghana. Located in the hub of industrial activity, the company is recognized as a pioneer in the manufacturing of high quality pharmaceutical drugs with a distribution network throughout West Africa. It was initially founded in May 1964 as Dannex Limited, a wholly owned private limited liability company, for the express purpose of manufacturing and distribution of pharmaceutical products. However, in 2014 and 2016 respectively, Dannex acquired majority shares in industry giants Starwin Products Limited (71.33%) and Ayrton Drug Manufacturing Limited (53.47%). All three companies were subsequently merged in 2019 to create Dannex Ayrton Starwin Plc.
Dannex Ayrton Starwin has a product range that includes tablets, capsules, liquids (syrups and suspensions), powders, ointments, chemicals (disinfectants) and veterinary products. With a strong distribution network, the company has wholesalers, retailers, and distribution points in all regions of Ghana. Additionally, they supply to other countries within the West African region.
Dannex Ayrton Starwin Plc is listed on the Ghana Stock Exchange (GSE) since January 15th, 2020. Dannex Ayrton Starwin is traded on the GSE under the ticker symbol “DASPHARMA”. The International Securities Identification Number (ISIN) of GSE:DASPHARMA is GHEDASP58306. Dannex Ayrton Starwin Plc is currently the 27th most valuable stock on the GSE with a market capitalization of GHS 32.2 million, which is about 0.041% of the Ghana Stock Exchange equity market.
| Last Trading Results | |
|---|---|
| Opening Price | |
| Day’s Low Price | |
| Day’s High Price | |
| Traded Volume | 0 |
| Number of Deals | 0 |
| Gross Turnover | 0.00 |
| Growth & Valuation | |
|---|---|
| Earnings Per Share | 0.0891 |
| Price/Earning Ratio | 4.26 |
| Dividend Per Share | 0.00 |
| Dividend Yield | 0% |
| Shares Outstanding | 84.8M |
| Market Capitalization | 32.2M |
DASPHARMA Stock Market Performance
| 1WK | 4WK | 3MO |
|---|---|---|
| -5% |
| 6MO | 1YR | YTD |
|---|---|---|
| -5% | -5% | -5% |
The current share price of Dannex Ayrton Starwin Plc (DASPHARMA) is GHS 0.38. DASPHARMA closed its last trading day (Friday, April 12, 2024) at 0.38 GHS per share on the Ghana Stock Exchange (GSE). Dannex Ayrton Starwin began the year with a share price of 0.40 GHS but has since lost 5% off that price valuation, ranking it 35th on the GSE in terms of year-to-date performance.
Dannex Ayrton Starwin is the 10th most traded stock on the Ghana Stock Exchange over the past three months (Jan 17 - Apr 18, 2024). DASPHARMA has traded a total volume of 149,913 shares valued at GHS 53,058 over the period, with an average of 2,380 traded shares per session. A volume high of 52,397 was achieved on February 13th for the same period. The table below details the last 10 trading days of activity of Dannex Ayrton Starwin on the Ghana Stock Exchange.
| Date | Volume | Close | Change | Change% |
|---|---|---|---|---|
| 2024-04-12 | 70 | 0.38 | ||
| 2024-04-09 | 80 | 0.38 | ||
| 2024-04-08 | 52,224 | 0.38 | ||
| 2024-04-04 | 100 | 0.38 | ||
| 2024-04-02 | 454 | 0.38 | ||
| 2024-03-21 | 246 | 0.38 | ||
| 2024-03-20 | 12 | 0.38 | ||
| 2024-03-11 | 369 | 0.38 | ||
| 2024-03-05 | 27 | 0.38 | ||
| 2024-03-01 | 260 | 0.38 |
Profile of Dannex Ayrton Starwin Plc
Dannex Ayrton Starwin Plc operates in the Health Care sector, specifically, the Pharmaceuticals & Biotechnology industry.
Factsheet of Dannex Ayrton Starwin Plc
- Sector
- Health Care
- Industry
- Pharmaceuticals & Biotechnology
- Address
- No. GA-172-1676, Shidaa Street, P. O. Box 5258, North Kaneshie, Accra, Ghana
- Telephone
- +233-302-232-574, +233-302-232-575, +233-26-372-9394
- info@dannexgh.com
- Website
- www.dannexgh.com
DASPHARMA Industrial Market Competitors
Dannex Ayrton Starwin Plc, issuers of the DASPHARMA stock on the Ghana Stock Exchange, have one market competitor who is also engaged in the Health Care sector and/or Pharmaceuticals & Biotechnology industry. The table below presents an overview of their market standing.
| Code | Name | M. Cap. | Close | YTD |
|---|---|---|---|---|
| IIL | Intravenous Infusions Limited | 12.9M | 0.05 |
